Bioquark, Inc. is a life sciences company developing proprietary combinatorial biologic products for both the regeneration and repair of human organs and tissues.
The company’s core program is focused on the development of novel combinatorial biologics capable of directly remodeling diseased, damaged, or aged tissues, creating micro-environments that induce efficient and controllable regeneration and repair.
Through a very novel approach of biologic regulatory state modification, we are capable of creating dynamics in mature tissues that are normally only seen during human fetal development, as well as during limb and organ regeneration in organisms like amphibians.
Developed as biologics, Bioquark’s therapeutics will be more amenable to existing regulatory pathways than technologies such as cell therapies, and avoid many limitations in the industry’s current offerings.
Founded in 2007, Bioquark Inc.’s corporate offices are located in Philadelphia, Pennsylvania.